Publication | Closed Access

Anti-fibrotic effect of thalidomide through inhibiting TGF-β-induced ERK1/2 pathways in bleomycin-induced lung fibrosis in mice

InflammationFibrosisAntifibrotic TherapyInflammatory Lung DiseaseBleomycin-induced Lung FibrosisLung InflammationMedicineAnti-fibrotic EffectImmunologyPulmonary PharmacologyPulmonary FibrosisPharmacotherapyPharmacologyTgf-β-induced Erk1/2